Calcium Orthophosphate-Based Bioceramics

Bone grafting techniques have evolved significantly since the 1960s when ceramics emerged as a promising alternative to traditional grafts. These materials were initially valued for their biomechanical compatibility with human bone. Over time, the term 'bioceramics' became widely used to describe synthetic materials with bone-like properties. Calcium orthophosphates gained attention due to their chemical resemblance to natural bone and teeth. Researchers shifted focus from merely biocompatible materials to those capable of forming direct chemical bonds with bone tissue. Structural and compositional adjustments allowed for control over whether implants remained stable or were resorbed. By the 2000s, regenerative bioceramics became a key part of tissue engineering strategies. These materials now support bone formation and vascularization through porous scaffolds.

This review aims to summarize the historical development and current applications of calcium orthophosphate-based bioceramics. It highlights the shift from passive bone substitutes to active regenerative materials. The study focuses on how structural and chemical modifications influence bioceramic performance. It also explores the transition from stable to resorbable formulations. The purpose is to evaluate how these materials integrate into tissue engineering. The review emphasizes their role in promoting bone regeneration and vascularization. It addresses the clinical uses of these bioceramics in bone augmentation and reconstruction. The goal is to assess their potential for future applications in drug delivery and cell-based therapies.

The review approach involved a systematic analysis of calcium orthophosphate-based bioceramics. It traced the historical progression from early biocompatible materials to modern regenerative formulations. The study compared the structural and chemical properties of different bioceramic types. It examined how porosity and biomolecule incorporation affect tissue regeneration. The approach included evaluating clinical applications such as bone augmentation and maxillofacial reconstruction. The researchers assessed the role of scaffolds in supporting cell growth and vascularization. They analyzed the transition from stable to resorbable materials through compositional control. The review also considered future directions like drug delivery and tissue engineering.

Calcium orthophosphate bioceramics can form direct chemical bonds with adjacent bone tissue. Structural and compositional adjustments allow for either stable or resorbable implants. Porous scaffolds enhance bone formation and vascularization by supporting cell growth. These materials are used in bone augmentation, spinal fusion, and periodontal repairs. They are also applied in maxillofacial reconstruction and tumor surgery bone fillers. The scaffolds often incorporate biomolecules and cells to promote tissue regeneration. By the 2000s, regenerative bioceramics became part of tissue engineering strategies. Future applications include drug delivery and as carriers for growth factors and bioactive peptides.

The authors propose that calcium orthophosphate bioceramics have evolved from passive bone substitutes to active regenerative materials. They suggest that structural and chemical modifications enable control over implant resorption. The review indicates that porous scaffolds enhance tissue regeneration and vascularization. These bioceramics are now used in various clinical applications like bone augmentation and spinal fusion. The authors suggest that future applications may include drug delivery and tissue engineering. They propose that these materials can serve as carriers for growth factors and bioactive peptides. The review highlights the importance of compositional control in achieving desired biological outcomes. The authors conclude that these bioceramics are promising for advancing regenerative medicine.